Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Submitted by
admin
on March 21, 2010 - 9:21am
Source:
Yahoo/AP
News Tags:
Reckitt Benckiser
Merck
narcotics
Suboxone
Subutex
Temgesic
Headline:
Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Do Not Allow Advertisers to Use My Personal information
